Prostate removal after hormone therapy for advanced prostate cancer
Treatments studied
Part of Cancer, Kidney & urinary clinical trials.
This trial is testing whether giving prostate removal surgery in addition to standard hormone therapy can help men with advanced prostate cancer that has spread to many places. It aims to see if this combination helps them live longer with a better quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 70 or younger, or your doctor expects you to live more than 10 more years.
- You have been newly diagnosed with prostate cancer that has spread (metastatic) and you are already on stronger hormone therapy that you started within the last 3 months.
- The cancer is considered 'high-volume,' meaning it has spread to at least 4 bones away from your spine/pelvis, or to organs like the liver or lungs.
- You are generally able to care for yourself (performance status 0-2) and your blood counts, liver, kidney, and clotting tests are within acceptable ranges.
- You have not had prostate removal surgery before, do not have a history of seizures or recent stroke, and have no major heart problems in the last 6 months.
- You do not have other active serious infections (like HIV, hepatitis B, or C) and you have not had another cancer in the past 3 years, except for a simple skin cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding surgery to remove the prostate and radiation to visible cancer spots, along with the usual hormone therapy, can help men with newly diagnosed prostate cancer that has spread. It aims to see if this more intensive approach can improve outcomes.
This trial tests whether adding a surgery called TURP (transurethral resection of the prostate) to the usual hormone therapy and chemotherapy can help men with metastatic prostate cancer that has spread to lymph nodes, bone, or other organs. The surgery helps relieve urinary symptoms and may improve how well the cancer responds to treatment.
This study tests if removing the prostate and giving strong hormone therapy works better than hormone therapy alone for men whose prostate cancer has spread. It aims to improve how long patients live without the cancer worsening.
This trial studies whether adding apalutamide to standard hormone therapy (ADT) improves outcomes for men with metastatic hormone-sensitive prostate cancer. Some people may also receive local treatments (like surgery or radiotherapy) to control the prostate and nearby areas.
This trial tests whether removing the prostate (surgery) plus standard hormone therapy and chemotherapy can help men whose prostate cancer has spread to many places in the body. It is for men who have not yet had treatment for their cancer.
This study tests adding a targeted local treatment (like radiation or surgery) to standard hormone therapy for men with advanced prostate cancer that still shows up on a special scan. The goal is to see if this combination helps control the cancer better.
Hear when a new Metastatic Prostate Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.